Trial Profile
A Single-centre, real-world study to evaluate Daratumumab in patients with Multiple Myeloma and Amyloidosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2018
Price :
$35
*
At a glance
- Drugs Daratumumab (Primary)
- Indications Amyloidosis; Multiple myeloma
- Focus Therapeutic Use
- 08 Oct 2018 New trial record